These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21180639)

  • 1. Immunomodulation and postpartum relapses in patients with multiple sclerosis.
    Hellwig K; Beste C; Schimrigk S; Chan A
    Ther Adv Neurol Disord; 2009 Jan; 2(1):7-11. PubMed ID: 21180639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period.
    Winkelmann A; Rommer PS; Hecker M; Zettl UK
    CNS Neurosci Ther; 2019 Jan; 25(1):78-85. PubMed ID: 29858532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis.
    Achiron A; Kishner I; Dolev M; Stern Y; Dulitzky M; Schiff E; Achiron R
    J Neurol; 2004 Sep; 251(9):1133-7. PubMed ID: 15372259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of postpartum intravenous immunoglobulins on the relapse rate among patients with multiple sclerosis.
    Brandt-Wouters E; Gerlach OH; Hupperts RM
    Int J Gynaecol Obstet; 2016 Aug; 134(2):194-6. PubMed ID: 27177509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins for the prevention of postpartum relapses in multiple sclerosis.
    Horvat Ledinek A; Brecl Jakob G; Jerše J; Ruška B; Pavičić T; Gabelić T; Barun B; Adamec I; Rot U; Šega Jazbec S; Krbot Skorić M; Habek M
    Mult Scler Relat Disord; 2020 Feb; 38():101519. PubMed ID: 31756610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulins as therapeutic option in the treatment of multiple sclerosis.
    Dudesek A; Zettl UK
    J Neurol; 2006 Sep; 253 Suppl 5():V50-8. PubMed ID: 16998754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis.
    Menascu S; Siegel-Kirshenbaum M; Dreyer-Alster S; Warszawer Y; Magalashvili D; Dolev M; Mandel M; Harari G; Achiron A
    Mult Scler J Exp Transl Clin; 2023; 9(1):20552173221151127. PubMed ID: 36687367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy in Multiple Sclerosis: A Portuguese cohort study.
    Jesus-Ribeiro J; Correia I; Martins AI; Fonseca M; Marques I; Batista S; Nunes C; Macário C; Almeida MC; Sousa L
    Mult Scler Relat Disord; 2017 Oct; 17():63-68. PubMed ID: 29055477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
    Portaccio E; Ghezzi A; Hakiki B; Sturchio A; Martinelli V; Moiola L; Patti F; Mancardi GL; Solaro C; Tola MR; Pozzilli C; De Giglio L; Totaro R; Lugaresi A; De Luca G; Paolicelli D; Marrosu MG; Comi G; Trojano M; Amato MP;
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):845-50. PubMed ID: 24403285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of disease-modifying treatments in multiple sclerosis to plan a pregnancy: A retrospective registry study.
    Villaverde-González R; Candeliere-Merlicco A; Alonso-Frías MA; Aparicio Castro E; Carrillo Alcaraz A; Mallada Frechín J; Pérez Sempere Á
    Mult Scler Relat Disord; 2020 Nov; 46():102518. PubMed ID: 32977075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of postpartum intravenous corticosteroids in the prevention of relapses in multiple sclerosis.
    Avila-Ornelas J; Avila M; Stosic M; Robles L; Prieto PG; Hutton GJ; Rivera VM
    Int J MS Care; 2011; 13(2):91-3. PubMed ID: 24453710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment Effectiveness for Resolution of Multiple Sclerosis Relapse in a US Health Plan Population.
    Nazareth T; Datar M; Yu TC
    Neurol Ther; 2019 Dec; 8(2):383-395. PubMed ID: 31564036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. There is no benefit in the use of postnatal intravenous immunoglobulin for the prevention of relapses of multiple sclerosis: findings from a systematic review and meta-analysis.
    Rosa GR; O'Brien AT; Nogueira EAG; Carvalho VM; Paz SC; Fragoso YD
    Arq Neuropsiquiatr; 2018 Jun; 76(6):361-366. PubMed ID: 29972417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks.
    Portaccio E; Moiola L; Martinelli V; Annovazzi P; Ghezzi A; Zaffaroni M; Lanzillo R; Brescia Morra V; Rinaldi F; Gallo P; Tortorella C; Paolicelli D; Pozzilli C; De Giglio L; Cavalla P; Cocco E; Marrosu MG; Solaro C; Uccelli A; Laroni A; Pastò L; Giannini M; Trojano M; Comi G; Amato MP;
    Neurology; 2018 Mar; 90(10):e832-e839. PubMed ID: 29438041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis and reproductive risks in women.
    Argyriou AA; Makris N
    Reprod Sci; 2008 Oct; 15(8):755-64. PubMed ID: 19017813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria.
    Bsteh G; Algrang L; Hegen H; Auer M; Wurth S; Di Pauli F; Deisenhammer F; Berger T
    Mult Scler; 2020 Jan; 26(1):69-78. PubMed ID: 30507345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy.
    Berenguer-Ruiz L; Gimenez-Martinez J; Palazón-Bru A; Sempere AP
    J Neurol; 2019 Oct; 266(10):2512-2517. PubMed ID: 31256279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of relapses during pregnancy among multiple sclerosis patients.
    Alroughani R; Akhtar S; Zeineddine M; El Kouzi Y; El Ayoubi NK; Ahmed SF; Behbehani R; Khoury SJ; Al-Hashel JY; Yamout BI
    Mult Scler Relat Disord; 2019 Sep; 34():9-13. PubMed ID: 31202959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS.
    Houtchens MK; Edwards NC; Phillips AL
    Neurology; 2018 Oct; 91(17):e1570-e1578. PubMed ID: 30266887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.